Document is current
Any future updates will be listed below
-
Authors
Michels, Veerle M. W. https://orcid.org/0009-0006-1587-7691
Szmul, Adam https://orcid.org/0000-0002-3068-1068
Jacob, Joseph https://orcid.org/0000-0002-8054-2293
Dejea, Hector https://orcid.org/0000-0003-2584-9812
de Bakker, Bernadette S. https://orcid.org/0000-0003-0758-4064
Huirne, Judith A. F. https://orcid.org/0000-0002-8248-2677
,
Dawood, Yousif
Docter, Daniël
Juffermans, Lynda J. M.
Burger, Nicole B.
Schoonhoven, Richard A.
Hanemaaijer - van der Veer, Jermo
Donner, Naem
Yamada, Daisuke
Egashira, Ryoko
Aslani, Shahab
Verleden, Stijn E.
Brunet, Joseph
Urban, Theresa
Purzycka, Joanna
Xue, Ruikang
Walsh, Claire L.
Lee, Peter D. https://orcid.org/0000-0002-3898-8881
Tafforeau, Paul
-
Funding
Funding for this research was provided by:
Chan Zuckerberg Initiative DAF (2022-316777)
Chan Zuckerberg Initiative DAF (2022-316777)
Chan Zuckerberg Initiative DAF (2022-316777)
Chan Zuckerberg Initiative DAF (2022-316777)
Chan Zuckerberg Initiative DAF (2022-316777)
Chan Zuckerberg Initiative DAF (2022-316777)
Chan Zuckerberg Initiative DAF (2022-316777)
Chan Zuckerberg Initiative DAF (2022-316777)
Chan Zuckerberg Initiative DAF (2022-316777)
Chan Zuckerberg Initiative DAF (2022-316777)
Chan Zuckerberg Initiative DAF (2022-316777)
Chan Zuckerberg Initiative DAF (2022-316777)
Chan Zuckerberg Initiative DAF (2022-316777)
Chan Zuckerberg Initiative DAF (2022-316777)
Chan Zuckerberg Initiative DAF (2022-316777)
Chan Zuckerberg Initiative DAF (2022-316777)
Chan Zuckerberg Initiative DAF (2022-316777)
Chan Zuckerberg Initiative DAF (2022-316777)
Chan Zuckerberg Initiative DAF (2022-316777)
Chan Zuckerberg Initiative DAF (2022-316777)
Chan Zuckerberg Initiative DAF (2022-316777)
Chan Zuckerberg Initiative DAF (2022-316777)
Chan Zuckerberg Initiative DAF (2022-316777)
Chan Zuckerberg Initiative DAF (2022-316777)
Amsterdam Reproduction and Development Research Institute (2024.01.005)
- License Information
-
More Information
Article History
Received: 19 August 2025
Accepted: 1 September 2025
First Online: 1 November 2025
Declarations
:
: J.J. declares consultancy fees from Boehringer Ingelheim, F. Hoffmann-La Roche, GlaxoSmithKline, NHSX; fees from advisory Boards for Boehringer Ingelheim, F. Hoffmann-La Roche; lecture fees from Boehringer Ingelheim, F. Hoffmann-La Roche, Takeda; grant funding from GlaxoSmithKline, Wellcome Trust (209553/Z/17/Z and 227835/Z/23/Z), Microsoft Research, Gilead Sciences, Chan Zuckerberg Initiative (CZIF2024-009938).
